Skip to content

Case study

Health Economics

Summary Swansea University

An independent evaluation by Swansea University (May 2024) confirms that Clinical Design Technologies’ Automated Urine Testing System (UTS™) provides clear and significant economic and operational advantages over traditional dipstick testing.

Despite higher consumable costs, UTS™ It delivers a 20.5% productivity increase, a Benefit-Cost Ratio of 2.17, and a Return on Investment (ROI) of 117%, with a payback period of less than one year.

By eliminating manual data entry, reducing test errors, and minimising waste, UTS™ not only lowers operational costs but also enhances patient safety and workflow efficiency. Its adoption unlocks long-term financial savings, improves compliance with quality standards, and strengthens clinical outcomes, offering a compelling case for healthcare organisations seeking to modernise and optimise diagnostic services.